Mov Disord Vol 31, Suppl 2 Archives - Page 190 of 207 - MDS Abstracts

2016 International Congress
Balance and gait disturbances in Parkinson’s disease patients with falls and freezing of gait
J. Stozek, M. Rudzinska, S. Bukowczan, A. Szczudlik (Cracow, Poland)
Objective: To assess balance and gait disturbances in Parkinson's disease (PD) patients with falls and freezing of gait (FOG). Background: Falls and freezing of gait…
2016 International Congress
The impact of STN DBS on kinetic tremor in Parkinson’s disease patients
S. Szlufik, M. Szumilas, J. Dutkiewicz, D. Koziorowski, T. Mandat, E. Slubowska (Warsaw, Poland)
Objective: The aim of the study is to evaluate the impact of STN DBS on kinetic tremor in PD patients in comparison to pharmacologically treated…
2016 International Congress
Botulinum toxin in cerebral palsy children with gait disorder: Different therapy approaches
G.S. Pilina (Izhevsk, Russia)
Objective: The purpose of this work was to study the effectiveness of different therapy approaches with Botulinum toxin type A (BTX-A) in Cerebral Palsy (CP)…
2016 International Congress
Sensor-based motor state detection in Parkinson’s disease to approach personalized therapy delivery
L.P. Roncoroni, M. Scholten, I. Hanci, A. Gharabagi, D. Weiss (Tübingen, Germany)
Objective: As primary objective, we acquire a data pool of medically-treated PD patients with motor fluctuations to determine the sensitivity and specificity of algorithms capable…
2016 International Congress
RE-024: Mechanism of action and efficacy in non-clinical models
M. Beconi, E. Monteagudo, A. Di Marco, S. Malancona, D. Elbaum, S. Harper (San Diego, CA, USA)
Objective: To confirm the mechanism of action of RE-024, and evaluate its activity in human cellular models and brain penetration in animal models. Background: Pantothenate…
2016 International Congress
Effects of subthalamic deep brain stimulation in motor and nonmotor function in Parkinson’s disease patients with parkin mutation
L.M. Oliveira, R.G. Cury, H.F. Chien, J.G. Santos, M.G. Ghilardi, R.B. Machado, E.T. Fonoff, B.R. Egberto (São Paulo, Brazil)
Objective: The aim of our study was to evaluate prospectively the changes in motor, nonmotor symptoms (NMS) and quality of life produced by subthalamic deep…
2016 International Congress
Toward clinical use of electrode localizations in deep brain stimulation therapy
S. Ewert, A. Horn, P. Plettig, M. Ruch, A. Kühn (Berlin, Germany)
Objective: To develop an open source software capable of performing electrode localizations certified for clinical use in deep brain stimulation therapy. Background: Deep brain stimulation…
2016 International Congress
Does body mass index influence outcome of deep brain stimulation in Parkinson’s patients?
H. Abboud, G. Genc, D. Reyes, N.R. Thompson, R. Cerejo, K. Wilson, A. Ahmed, M. Gostkowski, A. Machado, H.H. Fernandez (Cleveland, OH, USA)
Objective: To investigate if preoperative body mass index (BMI) can predict functional and quality of life (QOL) outcomes following deep brain stimulation surgery (DBS) in…
2016 International Congress
Morbidity and comorbidity of deep brain stimulation for Parkinson’s disease – A thirteen-years retrospective cohort study
S.Y. Chen, Y.H. Pan, S.H. Lin (Hualien, Taiwan)
Objective: To assess the surgical morbidity and comorbidity in 140 consecutive patients with various disease entities of movement disorders, epilepsy and obsessive-compulsive disorders that underwent…
2016 International Congress
A dopamine-dependent activity of the STN in the control of balance in Parkinson’s disease
G. Arnulfo, N.G. Pozzi, C. Palmisano, A. Canessa, J. Brumberg, C.A. Frigo, G. Pezzoli, F. Steigerwald, J. Volkmann, I.U. Isaias (Würzburg, Germany)
Objective: To investigate the activity of the subthalamic nucleus (STN), and its relation to nigro-striatal dopaminergic denervation, in control of balance in Parkinson's disease (PD).…